Final height in children with steroid-sensitive nephrotic syndrome

Pediatrics International

Volumn 49, Issue 5, 2007, Pages 623-625

  Motoyama, Osamu ^a   Iitaka, Kikuo ^b  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b Yamato City Hospital   (Japan)

Author keywords

Cyclosporin A; Final height; Nephrotic syndrome; Prednisolone; Steroid sensitive nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MIZORIBINE; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GROWTH RETARDATION; HUMAN; HYPOALBUMINEMIA; KIDNEY FUNCTION; MALE; NEPHROTIC SYNDROME; ONSET AGE; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE; SIBLING; STATISTICAL SIGNIFICANCE;

ADOLESCENT; BODY HEIGHT; CHILD; CYCLOSPORINE; FEMALE; HUMANS; MALE; NEPHROTIC SYNDROME; STEROIDS;

EID: 34548670069     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02429.x     Document Type: Article

References (11)

1. Motoyama O, Shigetomi Y, Iitaka K Cyclosporin treatment in steroid-dependent nephrotic syndrome of childhood. Effective CyA concentration (whole blood, monoclonal RIA) and the effect of growth velocity J. Jpn. Pediatr. Soc. 1997 101 : 1303 7 (in Japanese with English abstract).
2. Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid-responsive nephrotic syndrome. Lancet 1985 2 : 917 19.
3. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome. Come of age: long-term outcome. J. Pediatr. 2005 147 : 202 7.
4. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 2000 105 : 1242 9.
5. Suwa S, Tachibana K, Maesaka H, Tanaka H, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin. Pediatr. Endocrinol. 1992 1 : 5 13.
6. Tanaka T, Imai T Pubertal maturation in healthy girls and standardization of menarcheal age J. Jpn. Pediatr. Soc. 2005 109 : 1232 42 (in Japanese with English abstract).
7. Motoyama O, Shigetomi Y, Sawai K, Tateno A, Iitaka K. Convulsion during cyclosporin A therapy for nephrotic syndrome. Clin. Exp. Nephrol. 2000 4 : 63 6.
8. Kashtan C, Melvin T, Kim Y. Long-term follow-up of patients with steroid-dependent minimal change nephrotic syndrome. Clin. Nephrol. 1988 29 : 79 85.
9. Matsukura H, Inaba S, Shinozaki K et al. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome. Am. J. Nephrol. 2001 21 : 362 7.
10. Kitamura M Growth retardation in children with frequent relapsing nephrotic syndrome on steroid. Improvement of height velocity after administration of immunosuppressive agent Jpn. J. Nephrol. 1992 34 : 117 24 (in Japanese with English abstract).
11. Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr. Nephrol. 2003 18 : 783 8.